QIAscreen HPV PCR Test - India CDSCO Medical Device Registration

QIAscreen HPV PCR Test is a medical device registered with India's Central Drugs Standard Control Organization (CDSCO) under UID IMP/IVD/2023/000088_8c4e6e23734afe3cf0bbe804263e07db_e77b7f9db0caaa3c5a0876380f30e54b. This device is marketed under the brand name QIAscreen HPV PCR Test. The license holder is QIAGEN India Pvt. Ltd, and it is classified as Device Class Class C. The approving authority is CDSCO.

This page provides comprehensive regulatory information including complete registration details, license holder information, device classification, and related products. Pure Global AI offers free access to 71,807+ India medical device registrations, helping global MedTech companies identify partners, analyze markets, and discover business opportunities efficiently.

Free Database

CDSCO Registered

Class Class C

QIAscreen HPV PCR Test

UID: IMP/IVD/2023/000088_8c4e6e23734afe3cf0bbe804263e07db_e77b7f9db0caaa3c5a0876380f30e54b

Brand Name

QIAscreen HPV PCR Test

License Holder

QIAGEN India Pvt. Ltd

Device Class

Class C

Approving Authority

CDSCO

Product Information

The QIAscreen HPV PCR Test is an in vitro real-time PCR-based assay for the qualitative detection of human papillomavirus (QIAscreen HPV PCR Test) DNA of the following 15 (QIAscreen HPV PCR Test) high-risk HPV genotypes, i.e 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 66, 67, and 68. The assay is intended to be used for the screening of women for the risk of cervical (QIAscreen HPV PCR Test)cancer.